Integrated Cannabis Solutions, Inc.

CIK:0001002771|SEC Filings

UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS
Revenue	$ 0	$ 0	$ 0	$ 0
Operating expenses:
Salaries and wages	45,000	45,000	135,000	135,000
Selling, general and administrative	5,820	6,642	19,532	20,730
Professional and legal fees	49,241	29,354	114,727	102,533
Total operating expenses	100,061	80,996	269,259	258,263
Loss from operations	(100,061)	(80,996)	(269,259)	(258,263)
Other expense:
Interest expense	(15,851)	(13,067)	(44,621)	(33,330)
Total other expense	(15,851)	(13,067)	(44,621)	(33,330)
Net loss	$ (115,912)	$ (94,063)	$ (313,880)	$ (291,593)
Net loss per common share - basic and diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.00)
Weighted average number of shares outstanding - basic and diluted	1,667,284,450	1,533,317,059	1,644,763,945	1,500,533,176

UNAUDITED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (313,800)	$ (291,593)
Change in operating assets and liabilities:
Prepaid expenses	10,000	(7,000)
Accounts payable and accrued expenses	203,797	111,846
Net cash used in operating activities	(100,083)	(186,747)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of notes payable	21,000	161,083
Advances from officer	79,083	25,664
Net cash provided by financing activities	100,083	186,747
NET CHANGE IN CASH	0	0
Cash at beginning of year	0	0
CASH AT END OF YEAR	0	0
SUPPLEMENTAL DISCLOSURE FOR OPERATING ACTIVITIES:
Cash paid for interest	0	0
Cash paid for income taxes	0	0
NON-CASH FINANCING AND INVESTING ACTIVITIES:
Conversion of common stock for series A preferred stock	$ 5,000	$ 0

UNAUDITED CONSOLIDATED BALANCE SHEETS - USD ($)	Sep. 30, 2022	Dec. 31, 2021
current assets:
Prepaid expenses	$ 0	$ 10,000
Total assets	0	10,000
CURRENT Liabilities:
Accounts payable and accrued expenses	676,383	487,019
Accrued interest, related party	44,074	29,641
Note payable	419,919	398,919
Advances from officer	233,455	154,372
Total Liabilities	1,373,831	1,069,951
Stockholders' deficit:
Common stock, $0.0001 par value, 2,650,000,000 and 1,650,000,000 shares authorized, 1,683,317,059 and 1,633,317,059 shares issued and outstanding, respectively	168,332	163,332
Additional paid-in capital	2,604,845	2,609,845
Accumulated deficit	(4,147,161)	(3,833,281)
Total Stockholders' Deficit	(1,373,831)	(1,059,951)
Total liabilities and stockholders' deficit	0	10,000
Series B Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	0	0
Series A Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	99	99
Series C Preferred Stock [Member]
Stockholders' deficit:
Preferred stock, value	$ 54	$ 54